|
Mr. MAO Peng is the Chairman and Chief Executive Officer (CEO) of China Biopharmaceutical Holdings (CBH).Prior to founding CBH, Mr. Mao was the CEO of China Pharmaceuticals Investment Fund and managed the fund's investments in the pharmaceutical industry in China . Mr. Mao was also the co-founder and president of Infogroup Investment Corp., a Canadian company specializing in corporate finance and investment management. Mr. Mao graduated from Shandong University in 1993 with a B.A. degree in Marketing and graduated from the Lundquist College of Business at the University of Oregon in 1997 with an MBA degree. | 